INDP · Indaptus Therapeutics, Inc. · Exempt Offerings
$2.92
+0.19 (+6.96%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result of these uncertainties, there is substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$363.75M
Shares
133.24M
Volume · Oct 20
217.08K
Avg daily vol (3M)
875.16K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-06-20 | New | Pharmaceuticals | $5,000,000 | $2,314,800 | 06c |
| 2025-01-22 | New | Pharmaceuticals | $2,246,500 | $2,246,500 | 06b |
| 2024-12-06 | New | Pharmaceuticals | $227,127 | $227,127 | 06b |
| 2024-10-04 | Amendment | Pharmaceuticals | $205,480 | $205,480 | 06b |
| 2024-08-22 | New | Pharmaceuticals | $205,480 | $205,480 | 06b |
| 2021-08-05 | New | Pharmaceuticals | $30,000,000 | $30,000,000 | 06b |
Showing 1–6 of 6 filings